These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10335027)

  • 1. [Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections].
    Bocheńska-Marciniak M; Kupryś I; Krzywiecki A; Sliwowski A; Kuna P
    Pol Arch Med Wewn; 1998 Sep; 100(3):222-35. PubMed ID: 10335027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections.
    MacFarlane JT; Prewitt J; Gard P; Guion A
    Br J Gen Pract; 1996 Jun; 46(407):357-60. PubMed ID: 8983255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections.
    Allin D; James I; Zachariah J; Carr W; Cullen S; Middleton A; Newson P; Lytle T; Coles S
    Clin Ther; 2001 Dec; 23(12):1958-68. PubMed ID: 11813931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of spiramycin in the treatment of inflammatory diseases ot the respiratory tract in children in ambulatory conditions].
    Otsiians EN; Rziankina MF; D'iachenko VG; Suleĭmanov SSh; Zakharova EI; Bachaldina OM
    Antibiot Khimioter; 1998; 43(11):34-7. PubMed ID: 10079865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections].
    Gálvez-Múgica MA; Espinosa de los Monteros MJ; Gallego Sandín S; Novalbos J; Abad-Santos F
    Rev Esp Quimioter; 2003 Dec; 16(4):403-11. PubMed ID: 14961134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.
    Li XM; Wang FC; Yang F; Jin YH
    Chin Med J (Engl); 2013; 126(11):2179-85. PubMed ID: 23769580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.
    Tatsis G; Tsoukalas G; Boulbasakos G; Platsouka E; Anagnostopoulou M; Pirounaki M; Paniara O; Sioula E; Raptis J; Saroglou G
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():69-73. PubMed ID: 9579716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
    O'Neill SJ; Millar ED; Coles SJ; Bachand RT
    Ir Med J; 1991 Mar; 84(1):33-5. PubMed ID: 1828461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO; Ohaju-Obodo J
    West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
    Guay DR; Craft JC
    J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections.
    Macklin JL; James I; Kearsley NJ; Coles SJ
    J Chemother; 1993 Jun; 5(3):174-80. PubMed ID: 8371127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance.
    Anzueto A; Norris S
    Int J Antimicrob Agents; 2004 Jul; 24(1):1-17. PubMed ID: 15225854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.